-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Autolus Therapeutics plc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2016 to 2023.
- Autolus Therapeutics plc Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $22K.
- Autolus Therapeutics plc Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $40.5K, a 88.9% decline year-over-year.
- Autolus Therapeutics plc annual Income Tax Expense (Benefit) for 2023 was -$19.5K, a 107% decline from 2022.
- Autolus Therapeutics plc annual Income Tax Expense (Benefit) for 2022 was $272K, a 369% increase from 2021.
- Autolus Therapeutics plc annual Income Tax Expense (Benefit) for 2021 was $58K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)